| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.52B | 35.66B | 36.26B | 32.79B | 32.46B | 31.68B |
| Gross Profit | 36.52B | 33.80B | 35.49B | 31.97B | 32.00B | 31.04B |
| EBITDA | 5.27B | 6.61B | 4.63B | 4.09B | 6.74B | 4.27B |
| Net Income | 4.45B | 4.10B | 2.19B | 2.10B | 4.23B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 2.89T | 2.89T | 2.85T | 2.77T | 2.96T | 2.70T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 307.35B | 351.61B | 334.87B | 524.84B | 357.13B |
| Total Debt | 155.30B | 143.30B | 138.30B | 128.30B | 369.00B | 158.00B |
| Total Liabilities | 2.79T | 2.80T | 2.76T | 2.68T | 2.86T | 2.59T |
| Stockholders Equity | 98.14B | 91.75B | 97.14B | 91.02B | 104.10B | 112.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.17B | 0.00 | -263.47B | 218.45B | 0.00 |
| Operating Cash Flow | 0.00 | -8.80B | 0.00 | -261.93B | 220.00B | 0.00 |
| Investing Cash Flow | 0.00 | -86.31B | 18.44B | 59.37B | -34.66B | -30.96B |
| Financing Cash Flow | 0.00 | 39.01B | -464.00M | -431.00M | -424.00M | 151.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥39.80B | 24.09 | ― | 2.87% | 16.42% | 119.62% | |
69 Neutral | ¥67.24B | 6.31 | ― | 2.34% | -0.97% | 27.62% | |
68 Neutral | ¥39.85B | 10.62 | ― | 3.28% | 22.26% | -12.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥50.26B | 4.49 | ― | 1.20% | 8.45% | 168.74% | |
65 Neutral | ¥128.14B | 9.42 | ― | 0.58% | 15.03% | 16.66% | |
52 Neutral | ¥99.55B | 6.95 | ― | 2.12% | 10.91% | -1225.48% |